FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q1 2026
Top Holdings173 positions
ELECTRONIC ARTS INC | 7.5M | $1.5B | 8.0% | — | — | 2 qtrssince 2025-Q4 | Increased 85 |
| 2.3M | $1.5B | 7.8% | — | — | — | New — | |
REVOLUTION MEDICINES INC | 13.6M | $1.3B | 6.9% | $35.04 | +186.80% | 21 qtrssince 2021-Q1 | Decreased 0 |
AMAZON COM INC | 4.2M | $878.6M | 4.6% | $225.22 | -7.32% | 4 qtrssince 2025-Q2 | Decreased 0 |
MICROSOFT CORP | 2.3M | $868M | 4.6% | $340.17 | +8.38% | 30 qtrssince 2018-Q4 | Increased 62 |
AON PLC | 2.5M | $811M | 4.3% | $329.96 | -2.43% | 9 qtrssince 2024-Q1 | Decreased 0 |
BRIDGEBIO PHARMA INC | 9.4M | $695.5M | 3.6% | $38.71 | +91.85% | 7 qtrssince 2024-Q3 | Increased 60 |
| 3.6M | $690.9M | 3.6% | — | — | — | New — | |
PROTAGONIST THERAPEUTICS INC | 6.3M | $669.2M | 3.5% | $22.07 | +377.53% | 30 qtrssince 2018-Q4 | Increased 60 |
NATERA INC | 3.2M | $641.4M | 3.4% | $74.59 | +168.12% | 20 qtrssince 2021-Q2 | Decreased 0 |
EXELIXIS INC | 13.1M | $562.3M | 2.9% | $23.30 | +84.11% | 30 qtrssince 2018-Q4 | Decreased 0 |
BROADCOM INC | 1.8M | $550.8M | 2.9% | $326.98 | -5.49% | 2 qtrssince 2025-Q4 | Increased 87 |
UNITEDHEALTH GROUP INC | 1.8M | $492.9M | 2.6% | $412.83 | -35.23% | 13 qtrssince 2023-Q1 | Increased 61 |
SYNOPSYS INC | 1.2M | $481M | 2.5% | $456.80 | -13.20% | 2 qtrssince 2025-Q4 | Increased 64 |
BOSTON SCIENTIFIC CORP | 7.5M | $468.8M | 2.5% | $73.75 | -14.92% | 23 qtrssince 2020-Q3 | Increased 54 |
THERMO FISHER SCIENTIFIC INC | 881,485 | $433.3M | 2.3% | $462.49 | +6.09% | 26 qtrssince 2019-Q4 | Increased 71 |
KKR & CO INC | 4.7M | $432.1M | 2.3% | $107.09 | -13.96% | 2 qtrssince 2025-Q4 | Increased 86 |
LANTHEUS HLDGS INC | 5.6M | $423.5M | 2.2% | $78.29 | +0.70% | 13 qtrssince 2023-Q1 | Increased 55 |
WABTEC | 1.6M | $402.2M | 2.1% | $145.19 | +71.74% | 30 qtrssince 2018-Q4 | Decreased 0 |
CHARLES SCHWAB CORP (THE) | 4M | $371.8M | 1.9% | $77.32 | +18.93%as of Oct 16 | 6 qtrssince 2024-Q4 | Increased 58 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $19.1B across 173 positions as of Q1 2026. Top holdings: EA (8.0%), SPDR S&P 500 ETF TR puts (7.8%), RVMD (6.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
Active quarter - 48 new positions, 26 exits, 30 increased. Top move: AVGO (INCREASED, conviction 87). Portfolio: $19.1B across 173 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR